×

Premium Content - Please Submit to Continue:

First Name
Last Name
Company
Opt-In for Newsletter
Thank you!
Error - something went wrong!
   

State of eConsent 2017 Report - Site Edition

March 14, 2018 Jackie Brusch

eConsent is one of the newest and most exciting technological advancements in clinical trials, with potential to shape the way clinicians and subjects are able to interact on clinical studies,  bringing streamlined workflows and higher patient satisfaction to the entire informed consent process.

Subject recruitment and enrollment remain major challenges in clinical trials. Over 40% of clinical trials struggle to meet minimum enrolment goals, leaving many sponsors struggling to conduct trials.  In addition, 85% of clinical trials fail to retain enough patients, with the average dropout rate across all clinical trials as high as 30%.

As a follow-up to our 2017 State of eConsent industry report, CRF Health wanted to gather site staff opinions on the impacts the paper-based informed consent process has on participant understanding, recruitment and retention. 

This site-specific survey gathered feedback from 105 respondents in roles including study coordinator, CRA, investigator, and researcher. Whether your organization is just starting to consider eConsent or looking to expand adoption, we hope that these survey findings provide insight and context into the perspectives of site staff. 

About the Author

Jackie Brusch

Jackie Brusch is the Content Marketing Manager at CRF Health.

Previous Article
14 Drivers of eConsent Adoption
14 Drivers of eConsent Adoption

Next Video
Reducing Regulatory Risk with eConsent
Reducing Regulatory Risk with eConsent